Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC Patients

Consorzio Oncotech · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
breast-cancer
metastatic breast cancer, human epidermal growth factor 2 negative carcinoma of breast, breast cancer, her2negative, second line treatment, her2-, mbc, metastatic, bevacizumab, eribulin, human epidermal growth factor receptor 2-negative, interventional
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 800803
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.